Header cover image

Indian (NIFTY) Pharma Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies139
  • 7D1.7%
  • 3M-3.9%
  • 1Y16.7%
  • YTD7.6%

Over the last 7 days, the Pharma industry has risen 1.7%, driven by gains from Cipla of 8.3%. This takes the industry's 12 month performance to a gain of 17%.

Industry Valuation and Performance

Has the Indian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021₹10.3t₹2.7t₹359.9b21.3x
Tue, 26 Oct 2021₹10.4t₹2.6t₹378.6b24x
Thu, 23 Sep 2021₹10.9t₹2.6t₹375.7b26.1x
Sat, 21 Aug 2021₹10.6t₹2.6t₹375.2b24.2x
Sat, 05 Jun 2021₹10.4t₹2.5t₹332.3b22.6x
Tue, 09 Mar 2021₹8.9t₹2.5t₹320.8b19.4x
Mon, 30 Nov 2020₹8.7t₹2.4t₹243.2b22.8x
Thu, 03 Sep 2020₹7.8t₹2.3t₹212.3b21.2x
Sun, 07 Jun 2020₹6.7t₹2.3t₹223.9b17.5x
Sat, 29 Feb 2020₹5.6t₹2.3t₹210.7b15x
Tue, 03 Dec 2019₹5.7t₹2.3t₹234.5b15.7x
Fri, 06 Sep 2019₹5.2t₹2.2t₹212.4b15.6x
Mon, 10 Jun 2019₹5.4t₹2.1t₹201.0b17.2x
Sun, 03 Mar 2019₹5.7t₹2.1t₹192.8b18.9x
Wed, 05 Dec 2018₹6.1t₹2.0t₹181.5b20.4x
PE Ratio

20.4x

Total Market Cap: ₹6.1tTotal Earnings: ₹181.5bTotal Revenue: ₹2.0t0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 19.3x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 26% per year over the last three years, and revenues for these companies have grown 9.9% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Pharma industry?

Pharma1.70%

Industry PE: Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 19.3x. However analysts are expecting annual earnings growth of 21%, which is lower than the prior year's growth of 32% per year. So the market might believe that analysts are underestimating future growth.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 21% over the next 5 years. However this is lower than its past earnings growth rate of 32% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
CIPLA Cipla8.3%+₹60.1b29.7%PE30.1x
500420 Torrent Pharmaceuticals9.0%+₹42.4b16.3%PE40.6x
AUROPHARMA Aurobindo Pharma6.1%+₹22.9b-21.9%PE7.6x
540222 Laurus Labs8.6%+₹22.3b65.0%PE27.7x
GLENMARK Glenmark Pharmaceuticals10.3%+₹14.0b12.9%PE14.4x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GLENMARK

₹532.20

Glenmark Pharmaceuticals

7D

10.3%

1Y

12.9%